Grant: Collaborative Research and Development Grants
University of Guelph
$30,000.00
Enhancing Immunity to Marek's disease
FY 2006-07
Summary
The occurrence of infectious diseases in domestic animals is of great importance to human and animal health. Moreover, these diseases impose significant economic losses to the food animal industry. Marek's disease (MD) is a disease of chickens caused by a virus, Marek's disease virus or MDV, and is marked by formation of lymphomas, or cancer of immune system cells. This disease provides a unique model for studying the role of immune system and the genes, which control the immune mediators, in conferring resistance to disease. Interestingly, Marek's disease is probably the first cancer against which a commercial vaccine became available. However, little is known about the immunological mechanisms of resistance to disease. The proposed program is intended to investigate, at the molecular and cellular levels, the immunological elements involved in protection mediated by MD vaccines. Cells of the immune system, such as T cells, have been shown to be important in protection against viral insults. The objectives of this program are: 1- To elucidate the role of a set of immune system mediators called cytokines in immunity against MD, 2- To investigate the cause and effect relationship between cytokine genes and immunity to MD, 3- To employ cytokines to improve immunity against this disease. It is expected that findings of the proposed studies will expand our understanding of immunity to MD and will identify novel approaches for enhancing resistance against this disease.
Program
Collaborative Research and Development Grants
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
342498-2006
Name nom
Sharif, Shayan
Department département
Pathobiology
Organization id
24
Institution établissement
University of Guelph
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2006
Competition year année de concours
2006
Award amount
30000
Program id
CRDPJ
Program name en
Collaborative Research and Development Grants
Program name fr
Subventions de recherche et développement coopérative
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
102
Area of application group en
Agriculture and primary food production
Area of application group fr
Agriculture et produits alimentaires primaires
Area of application en
Animal management (animal diseases, breeding)
Area of application fr
Gestion des animaux (maladies animales, reproduction)
Research subject code
5500
Research subject group en
Animal biology
Research subject group fr
Biologie animale
Research subject en
Animal biology
Research subject fr
Biologie animale
Partie
1
Nb partie
2
Application title
Enhancing Immunity to Marek's disease
Keyword
NA
Application summary
The occurrence of infectious diseases in domestic animals is of great importance to human and animal health. Moreover, these diseases impose significant economic losses to the food animal industry. Marek's disease (MD) is a disease of chickens caused by a virus, Marek's disease virus or MDV, and is marked by formation of lymphomas, or cancer of immune system cells. This disease provides a unique model for studying the role of immune system and the genes, which control the immune mediators, in conferring resistance to disease. Interestingly, Marek's disease is probably the first cancer against which a commercial vaccine became available. However, little is known about the immunological mechanisms of resistance to disease. The proposed program is intended to investigate, at the molecular and cellular levels, the immunological elements involved in protection mediated by MD vaccines. Cells of the immune system, such as T cells, have been shown to be important in protection against viral insults. The objectives of this program are: 1- To elucidate the role of a set of immune system mediators called cytokines in immunity against MD, 2- To investigate the cause and effect relationship between cytokine genes and immunity to MD, 3- To employ cytokines to improve immunity against this disease. It is expected that findings of the proposed studies will expand our understanding of immunity to MD and will identify novel approaches for enhancing resistance against this disease.